Arrhythmias & electrophysiology

Cholesterol profiles and cholesterol-lowering medication in relation to the incidence of atrial fibrillation

Heart RhythmPublished Prospective cohort study

Authors' conclusion

Cholesterol and lipoprotein subfractions were heterogeneously associated with AF risk, potentially reflecting the biological effects of the distribution of different lipoprotein carriers and their cholesterol cargo, whereas cholesterol-lowering medication was linked to higher AF incidence.

Study context

Population
UK Biobank participants without baseline CVDmedication cohort n = 394,718
Participants
187,680 participants
Exposure
Cholesterol profiles, particle numbers, apolipoproteins and cholesterol-lowering medication vs atrial fibrillation (AF) incidence
Outcome
Incident AF
Methodological detailsUK Biobank, NMR spectroscopy lipid profiling, Cox and Fine-Gray competing risk models, restricted cubic spline analyses
  • UK Biobank
  • NMR spectroscopy lipid profiling
  • Cox and Fine-Gray competing risk models
  • Restricted cubic spline analyses

Main finding

As reported in the abstract

  • Total, LDL, IDL, VLDL, remnant and TG-rich lipoprotein remnant cholesterol inversely associated with AF
  • High-density lipoprotein cholesterol (HDL-C) positively associated with AF
  • Small HDL-C associated with lower AF risk; large and very large HDL-C with higher risk
  • Generally linear associations (restricted cubic splines)
  • Particle numbers: small HDL particles inverse, large HDL particles positive associations

Observational data: associations, not effects.

Further findings

Adjustment for apolipoproteins

LDL-C and IDL cholesterol associations attenuated or reversed; HDL-related associations persisted

Lecithin-cholesterol acyltransferase

Correlated with higher small HDL-C vs lower large HDL-C, in line with their associations with AF

Cholesterol-lowering medication (mainly statins) and AF incidence

Modestly associated with higher AF incidence
  • Separate cohort n = 394,718

Original publication

Cholesterol profiles and cholesterol-lowering medication in relation to the incidence of atrial fibrillation. Heart Rhythm. Published 17 November 2025. doi:10.1016/j.hrthm.2025.11.021

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.